Altamira Therapeutics Ltd. — F-3 Filings
9 F-3 filings on record
This page lists all F-3 filings submitted to the SEC by Altamira Therapeutics Ltd. (CYTOF), sorted by most recent first. Each row links to the full filing on EdgarLookup. Altamira Therapeutics Ltd. has filed 9 F-3 documents with the SEC since 2014. To view all SEC filings by Altamira Therapeutics Ltd., see the full filings list.
All
15-12G
15F-12B
20-F
20-F/A
25-NSE
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
8-K12G3
CERT
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
FWP
NT 20-F
POS AM
POS EX
RW
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| F-3 | REGISTRATION STATEMENT | 0001213900-24-001961 | Jan 8, 2024 | — |
| F-3 | REGISTRATION STATEMENT | 0001213900-23-045067 | Jun 1, 2023 | — |
| F-3 | REGISTRATION STATEMENT | 0001213900-22-058423 | Sep 23, 2022 | — |
| F-3 | REGISTRATION STATEMENT | 0001213900-22-019867 | Apr 14, 2022 | — |
| F-3 | REGISTRATION STATEMENT | 0001213900-21-060092 | Nov 16, 2021 | — |
| F-3 | REGISTRATION STATEMENT | 0001213900-20-030341 | Oct 6, 2020 | — |
| F-3 | FORM F-3 | 0000950103-18-012924 | Nov 1, 2018 | — |
| F-3 | FORM F-3 | 0000950103-17-003560 | Apr 14, 2017 | — |
| F-3 | FORM F-3 | 0000950103-15-007026 | Sep 1, 2015 | — |